Department of Otorhinolaryngology-Head and Neck Surgery, Soon Chun Hyang University Hospital, Soon Chun Hyang University, Seoul, South Korea.
Department of Otorhinolaryngology-Head and Neck Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Laryngoscope. 2019 Nov;129(11):2451-2457. doi: 10.1002/lary.27866. Epub 2019 Feb 22.
OBJECTIVES/HYPOTHESIS: Sinonasal cancers are rare but have a poor prognosis. Most previous studies of these cancers have focused on 5-year disease-free survival, but recurrences are also known to occur after this period. We examined the post-5-year recurrence patterns in sinonasal cancer patients by histologic type to determine the indicators for extended and close follow-up requirements.
Retrospective chart review.
A cohort of 241 sinonasal cancer patients was included. Demographic data, cancer site and stage, pathology and treatment results, and follow-up and survival data were collected.
Of the 241 patients, a complete remission occurred in 163 (72.4%) patients, but 83 (50.9%) of these cases developed recurrence, which occurred beyond the 5-year follow-up period in 19 cases (11.7%). The most common post-5-year recurrences were adenoid cystic carcinoma (six patients, 33.3%), followed by melanoma (three patients, 21.4%), poorly differentiated carcinoma (two patients, 18.2%), squamous cell carcinoma (six patients, 6.7%), and olfactory neuroblastoma (no patients, 0%). Post-5-year local recurrence was highest in adenoid cystic carcinoma (six patients, 33.3%), followed by melanoma (three patients, 21.4%), poorly differentiated carcinoma (two patients, 18.2%), and squamous cell carcinoma (five patients, 5.5%). Post-5-year regional recurrence occurred in one squamous carcinoma patient (1.1%), and distant metastasis was seen in one adenoid cystic carcinoma patient (5.5%).
Sinonasal cancer shows an 11.7% recurrence rate after a 5-year disease-free period. As this recurrence pattern varies by tumor pathology, a specific follow-up plan is needed for each cancer type.
3 Laryngoscope, 129:2451-2457, 2019.
目的/假设:鼻窦癌较为罕见,但预后较差。大多数关于鼻窦癌的既往研究都集中在 5 年无病生存率上,但也已知在此期间后会发生复发。我们通过组织学类型检查鼻窦癌患者的 5 年后复发模式,以确定需要延长和密切随访的指标。
回顾性图表审查。
纳入了 241 例鼻窦癌患者。收集了人口统计学数据、癌症部位和分期、病理和治疗结果以及随访和生存数据。
在 241 例患者中,163 例(72.4%)患者完全缓解,但其中 83 例(50.9%)出现复发,19 例(11.7%)在 5 年随访期后发生复发。最常见的 5 年后复发是腺样囊性癌(6 例,33.3%),其次是黑色素瘤(3 例,21.4%)、低分化癌(2 例,18.2%)、鳞状细胞癌(6 例,6.7%)和嗅神经母细胞瘤(无,0%)。腺样囊性癌 5 年后局部复发率最高(6 例,33.3%),其次是黑色素瘤(3 例,21.4%)、低分化癌(2 例,18.2%)和鳞状细胞癌(5 例,5.5%)。1 例鳞状细胞癌患者发生 5 年后区域复发(1.1%),1 例腺样囊性癌患者发生远处转移(5.5%)。
鼻窦癌在无疾病 5 年后的复发率为 11.7%。由于这种复发模式因肿瘤病理而异,因此需要为每种癌症类型制定特定的随访计划。
3 Laryngoscope, 129:2451-2457, 2019.